Cisen Pharmaceutical Co., Ltd. (SHA:603367)

HashiCorp Revenue

Cisen Pharmaceutical had revenue of 920.20M CNY in the quarter ending March 31, 2025, a decrease of -19.91%. This brings the company's revenue in the last twelve months to 3.75B, down -16.17% year-over-year. In the year 2024, Cisen Pharmaceutical had annual revenue of 3.98B, down -10.77%.

• Revenue (ttm): 3.75B
• Revenue Growth: -16.17%
• P/S Ratio: 3.64
• Revenue / Employee: 1.14M
• Employees: 3,302
• Market Cap: 13.67B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.98B	-480.78M	-10.77%
Dec 31, 2023	4.46B	396.26M	9.75%
Dec 31, 2022	4.07B	283.50M	7.49%
Dec 31, 2021	3.78B	108.43M	2.95%
Dec 31, 2020	3.67B	-438.63M	-10.66%